China NMPA Approves Spuqibai Monoclonal Antibody Injection for Market

📩 info@dengyuemed.com
🔗https://dengyuemed.com

#KeymedBio #StapokibartInjection #InnovativeDrugs #AtopicDermatitis #IL4RAntibody #BiopharmaChina #BiotechInnovation #ChinesePharmaceuticals #DrugApproval #Biologics

🌟 Stapokibart (KEYMEDBIO): PD-L1 Immunotherapy! 🌟
💊 Blocks PD-L1 to restore immune response.
⚡ Treats advanced solid tumors with precision.

🔗 Learn more: dengyuemed.com/product/keym...

#HongKongDrugWholesaleDistributor
#HongKongDengYueMedicine
#KEYMEDBIO #Stapokibart #PDL1Antibody #Immunotherapy